By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Keryx Biopharmaceuticals 

750 Lexington Avenue, 26th Floor

New York  New York  10022  U.S.A.
Phone: 212-531-5965 Fax: 212-531-5961



Company News
Keryx (KERX) Announces Two National Insurance Providers Added Auryxia To Their Medicare Part D Formularies 6/24/2015 11:59:09 AM
Keryx (KERX) To Present At The JMP Securities Life Sciences Conference 2015 6/16/2015 10:53:39 AM
A Battle is Brewing Between Keryx (KERX)'s Largest Backer and Short Investors 5/13/2015 6:24:33 AM
Keryx (KERX) Transitions to Boston Pharma Hub, Prepares Hiring Expansion 5/8/2015 5:58:26 AM
Keryx (KERX) To Present A Bank of America (BAC) Merrill Lynch 2015 Health Care Conference 5/6/2015 1:31:33 PM
Keryx Biopharmaceuticals (KERX) Announces First Quarter 2015 Financial Results 5/4/2015 10:58:50 AM
Keryx Biopharmaceuticals (KERX) Completes Transition Of CEO Role To Greg Madison 5/1/2015 7:31:07 AM
Keryx Biopharmaceuticals (KERX) To Host Conference Call On First Quarter 2015 Financial Results 4/28/2015 7:52:52 AM
Keryx Biopharmaceuticals (KERX) Appoints John F. Neylan, MD, As Chief Medical Officer 4/23/2015 10:58:55 AM
Keryx Biopharmaceuticals (KERX) Announces Appointment Of Greg Madison To Its Board Of Directors 3/11/2015 7:45:53 AM